CHRISTINA BURGE: Open Payments
NPI 1861087058 · SARASOTA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,806 in 48 payments from 16 companies in 2025. Trend: 2023 $2,759 · 2024 $976 · 2025 $1,806
Food & beverage: $1,806
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $367 |
| Alkermes, Inc. | 7 | $287 |
| E.R. Squibb & Sons, L.L.C. | 5 | $204 |
| ABBVIE INC. | 7 | $159 |
| Neurocrine BioSciences, Inc. | 2 | $154 |
| Axsome Therapeutics, Inc. | 3 | $151 |
| Otsuka America Pharmaceutical, Inc. | 5 | $124 |
| Vanda Pharmaceuticals Inc. | 3 | $102 |
| Janssen Pharmaceuticals, Inc | 1 | $50 |
| Supernus Pharmaceuticals, Inc. | 2 | $43 |
Products named: CAPLYTA, COBENFY, LYBALVI, VRAYLAR, INGREZZA, Auvelity, REXULTI, FANAPT.
Industry payments across FL — which companies pay providers there.
